Somatostatin receptor-targeted radiopeptide therapy with 90Y-DOTATOC and 177Lu-DOTATOC in progressive meningioma: long-term results of a phase II clinical trial.
about
PET Imaging in Patients with Meningioma - Report of the RANO/PET Group.68Gallium-DOTATATE PET in meningioma: A reliable predictor of tumor growth rate?Somatostatin receptor-targeted radionuclide therapy for progressive meningioma: benefit linked to 68Ga-DOTATATE/-TOC uptakeAn overview of meningiomas
P2860
Somatostatin receptor-targeted radiopeptide therapy with 90Y-DOTATOC and 177Lu-DOTATOC in progressive meningioma: long-term results of a phase II clinical trial.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Somatostatin receptor-targeted ...... of a phase II clinical trial.
@en
Somatostatin receptor-targeted ...... of a phase II clinical trial.
@nl
type
label
Somatostatin receptor-targeted ...... of a phase II clinical trial.
@en
Somatostatin receptor-targeted ...... of a phase II clinical trial.
@nl
prefLabel
Somatostatin receptor-targeted ...... of a phase II clinical trial.
@en
Somatostatin receptor-targeted ...... of a phase II clinical trial.
@nl
P2093
P1476
Somatostatin receptor-targeted ...... of a phase II clinical trial.
@en
P2093
Helmut R Maecke
Jan Müller-Brand
Nicolas Marincek
Philippe Brunner
Piotr Radojewski
Rebecca A Dumont
P304
P356
10.2967/JNUMED.114.147256
P407
P577
2015-01-15T00:00:00Z